AstraZeneca Canada Inc. v. Apotex Inc.

AstraZeneca Canada Inc. v. Apotex Inc.

The appeals were dismissed because the motions judge found no legal error or misapprehension of fact in the Prothonotary’s exercise of discretion on numerous discovery questions; the Prothonotary appropriately balanced relevance, burden and fairness under the Federal Court Rules and deference is warranted absent questions vital to trial or clear error; therefore the Prothonotary’s orders compelling some answers and refusing others were upheld and costs awarded to AstraZeneca.

Citation
2008 FC 1301
Parties
Plaintiff: AstraZeneca Canada Inc.; Plaintiff: Aktiebolaget Hässle; Defendant; Plaintiff by Counterclaim: Apotex Inc.; Defendant by Counterclaim: AstraZeneca AB
Court
Federal Court
Jurisdiction
Canada
Judgment Date
21 November 2008
Procedural Posture
Patent Litigation – Discovery Disputes (appeal From Prothonotary) / Motions/discovery Appeal Prior to Trial
Outcome
Appeals dismissed
Legal Topics
Discovery, Oral Examination for Discovery, Document Production, Standard of Review of Prothonotary, Relevance, Costs
Source Language
English
Civil Procedure Intellectual Property Administrative Law Discovery Oral Examination for Discovery Document Production Standard of Review of Prothonotary Relevance +1 more

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Legal principles 7 Authorities cited 12 Party arguments 2
Sign in to unlock

Parties

AstraZeneca Canada Inc.

Plaintiff

Aktiebolaget Hässle

Plaintiff

Apotex Inc.

Defendant; Plaintiff by Counterclaim

AstraZeneca AB

Defendant by Counterclaim

Procedural Posture

Patent Litigation – Discovery Disputes (appeal From Prothonotary) / Motions/discovery Appeal Prior to Trial

Legal Issues

  1. 1 Whether the Prothonotary erred in ordering Apotex’s representative to answer certain discovery questions
  2. 2 Whether the Prothonotary erred in refusing to order AstraZeneca’s representative to answer certain discovery questions
  3. 3 Proper scope and limits of oral discovery under the Federal Court Rules

Ratio Decidendi

The appeals were dismissed because the motions judge found no legal error or misapprehension of fact in the Prothonotary’s exercise of discretion on numerous discovery questions; the Prothonotary appropriately balanced relevance, burden and fairness under the Federal Court Rules and deference is warranted absent questions vital to trial or clear error; therefore the Prothonotary’s orders compelling some answers and refusing others were upheld and costs awarded to AstraZeneca.

Court Disposition

Appeals dismissed

Orders

  • The two appeals brought by Apotex Inc. in respect of the Order of Prothonotary Lafrenière dated July 15, 2008 are dismissed
  • Costs are awarded to AstraZeneca